The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class...

A team of researchers affiliated with several entities in Thailand, working with two colleagues from the US and two from Canada, has developed an mRNA COVID-19 vaccine that can be safely refrigerated for up to three months before use....